# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-21-024732
Filing Date
2021-07-19
Accepted
2021-07-19 16:05:54
Documents
29
Period of Report
2021-07-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | brhc10026994_form8k.htm iXBRL | 8-K | 51157
2 | EXHIBIT 10.1 | brhc10026994_ex10-1.htm | EX-10.1 | 636421
3 | EXHIBIT 10.2 | brhc10026994_ex10-2.htm | EX-10.2 | 162807
4 | EXHIBIT 99.1 | brhc10026994_ex99-1.htm | EX-99.1 | 18950
5 | EXHIBIT 99.2 | brhc10026994_ex99-2.htm | EX-99.2 | 21470
9 |  | brhc10026994_ex99-2slide1.jpg | GRAPHIC | 118783
10 |  | brhc10026994_ex99-2slide2.jpg | GRAPHIC | 248966
11 |  | brhc10026994_ex99-2slide3.jpg | GRAPHIC | 140946
12 |  | brhc10026994_ex99-2slide4.jpg | GRAPHIC | 147375
13 |  | brhc10026994_ex99-2slide5.jpg | GRAPHIC | 113764
14 |  | brhc10026994_ex99-2slide6.jpg | GRAPHIC | 73917
15 |  | brhc10026994_ex99-2slide7.jpg | GRAPHIC | 127955
16 |  | brhc10026994_ex99-2slide8.jpg | GRAPHIC | 125903
17 |  | brhc10026994_ex99-2slide9.jpg | GRAPHIC | 113058
18 |  | brhc10026994_ex99-2slide10.jpg | GRAPHIC | 133150
19 |  | brhc10026994_ex99-2slide11.jpg | GRAPHIC | 140000
20 |  | brhc10026994_ex99-2slide12.jpg | GRAPHIC | 158170
21 |  | logo1.jpg | GRAPHIC | 10559
| Complete submission text file | 0001140361-21-024732.txt |  | 3483491

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | btx-20210716.xsd | EX-101.SCH | 3929
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | btx-20210716_lab.xml | EX-101.LAB | 22544
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | btx-20210716_pre.xml | EX-101.PRE | 16047
22 | EXTRACTED XBRL INSTANCE DOCUMENT | brhc10026994_form8k_htm.xml | XML | 5090

Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 211097971
SIC: 2834 Pharmaceutical Preparations